Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Definitive Healthcare (DH) Depreciation & Amortization (CF) (2020 - 2025)

Definitive Healthcare (DH) has disclosed Depreciation & Amortization (CF) for 6 consecutive years, with $991000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Depreciation & Amortization (CF) rose 88.4% year-over-year to $991000.0, compared with a TTM value of $3.3 million through Dec 2025, up 47.13%, and an annual FY2025 reading of $3.3 million, up 47.13% over the prior year.
  • Depreciation & Amortization (CF) was $991000.0 for Q4 2025 at Definitive Healthcare, up from $853000.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $991000.0 in Q4 2025 and bottomed at $341000.0 in Q1 2021.
  • Average Depreciation & Amortization (CF) over 5 years is $572250.0, with a median of $540000.0 recorded in 2024.
  • The sharpest move saw Depreciation & Amortization (CF) tumbled 38.65% in 2023, then surged 88.4% in 2025.
  • Year by year, Depreciation & Amortization (CF) stood at $558000.0 in 2021, then dropped by 15.41% to $472000.0 in 2022, then rose by 19.07% to $562000.0 in 2023, then fell by 6.41% to $526000.0 in 2024, then soared by 88.4% to $991000.0 in 2025.
  • Business Quant data shows Depreciation & Amortization (CF) for DH at $991000.0 in Q4 2025, $853000.0 in Q3 2025, and $868000.0 in Q2 2025.